Analyst Ratings for Quest Diagnostics (DGX)
DGX Rating Summary
DGX Price Target Summary
- Highest: $235.00 (Mizuho)
- Lowest: $200.00 (Piper Sandler)
- Average: $216.82
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$216.82 (+8.8%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 45%
Avg. $ Target:
$216.82 (+8.8%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 45%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/2/2026 | Barclays » Updated 2/11/2026 |
Luke Sergott | Upgrade | Overweight (Equalweight) |
225.00 (210.00) |
182.35 (199.21) |
9.25% | Details |
| 8/25/2025 | Baird » Updated 2/11/2026 |
Eric Coldwell | Downgrade | Neutral (Outperform) |
219.00 (203.00) |
183.72 (199.21) |
8.43% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
